Update: Influenza A (H3N2)v transmission and guidelines - five states, 2011.
about
Challenges and Strategies of Laboratory Diagnosis for Newly Emerging Influenza Viruses in Taiwan: A Decade after SARSPhylogenetic analysis of a swine influenza A(H3N2) virus isolated in Korea in 2012Induced opening of influenza virus neuraminidase N2 150-loop suggests an important role in inhibitor bindingMultiple contributory factors to the age distribution of disease cases: a modeling study in the context of influenza A(H3N2v)Antiviral susceptibility of variant influenza A(H3N2)v viruses isolated in the United States from 2011 to 2013Evolution of novel reassortant A/H3N2 influenza viruses in North American swine and humans, 2009-2011The neuraminidase and matrix genes of the 2009 pandemic influenza H1N1 virus cooperate functionally to facilitate efficient replication and transmissibility in pigsOutbreak of influenza A (H3N2) variant virus infection among attendees of an agricultural fair, Pennsylvania, USA, 2011Protective efficacy of a high-growth reassortant swine H3N2 inactivated vaccine constructed by reverse genetic manipulationResistance to Mutant Group 2 Influenza Virus Neuraminidases of an Oseltamivir-Zanamivir Hybrid Inhibitor.Pandemic influenza planning, United States, 1978-2008.Outbreak of variant influenza A(H3N2) virus in the United States.Human cytotoxic T lymphocytes directed to seasonal influenza A viruses cross-react with the newly emerging H7N9 virusModified vaccinia virus Ankara expressing the hemagglutinin of pandemic (H1N1) 2009 virus induces cross-protective immunity against Eurasian 'avian-like' H1N1 swine viruses in mice.Cellular and humoral cross-immunity against two H3N2v influenza strains in presumably unexposed healthy and HIV-infected subjects.Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years OldSeroprotective antibodies to 2011 variant influenza A(H3N2v) and seasonal influenza A(H3N2) among three age groups of US Department of Defense service members.Refining the approach to vaccines against influenza A viruses with pandemic potential.The Microminipig as an Animal Model for Influenza A Virus Infection.Pathogenicity and transmission in pigs of the novel A(H3N2)v influenza virus isolated from humans and characterization of swine H3N2 viruses isolated in 2010-2011.Serologic evidence of human influenza virus infections in swine populations, Cambodia.Global transmission of influenza viruses from humans to swine.H3N2v and other influenza epidemic risk based on age-specific estimates of sero-protection and contact network interactions.Using routine surveillance data to estimate the epidemic potential of emerging zoonoses: application to the emergence of US swine origin influenza A H3N2v virus.Estimates of the number of human infections with influenza A(H3N2) variant virus, United States, August 2011-April 2012.Using sequence data to infer the antigenicity of influenza virus.Observations of immuno-gold conjugates on influenza viruses using waveguide-mode sensorsEgg-adaptive mutations in H3N2v vaccine virus enhance egg-based production without loss of antigenicity or immunogenicityPhylogeography of swine influenza H3N2 in the United States: translational public health for zoonotic disease surveillanceSeasonal trivalent inactivated influenza vaccine does not protect against newly emerging variants of influenza A (H3N2v) virus in ferretsSubclinical influenza virus A infections in pigs exhibited at agricultural fairs, Ohio, USA, 2009-2011.A novel M2e-multiple antigenic peptide providing heterologous protection in mice.Reassortment complements spontaneous mutation in influenza A virus NP and M1 genes to accelerate adaptation to a new hostMolecular evidence for interspecies transmission of H3N2pM/H3N2v influenza A viruses at an Ohio agricultural fair, July 2012Antigenic characterization of H3N2 influenza A viruses from Ohio agricultural fairsHuman miR-3145 inhibits influenza A viruses replication by targeting and silencing viral PB1 gene.Recognition of influenza H3N2 variant virus by human neutralizing antibodies.Exploration of risk factors contributing to the presence of influenza A virus in swine at agricultural fairs.Seasonal H3N2 and 2009 Pandemic H1N1 Influenza A Viruses Reassort Efficiently but Produce Attenuated Progeny.Investigation of an Outbreak of Variant Influenza A(H3N2) Virus Infection Associated With an Agricultural Fair-Ohio, August 2012.
P2860
Q26796331-738F403A-2A16-4B34-AC7F-06D3B2B10E3DQ27322031-DB67278A-5F95-4282-B70C-59D00D7CE4E4Q27677074-B6266B8F-1BAD-409F-9786-EA16943A14C4Q28384700-CAD2F7A4-7975-4DA6-B481-C13BC2988F10Q28386096-FF5634CC-C6DF-4104-A204-2DDEA1B0816CQ28387606-6A037C80-B9BA-4EE3-9F72-5ABD926F7220Q28387864-D5232C31-3012-4D96-85E5-D271B1AFEA3EQ28393774-CB3D8225-CAEC-4A2A-B04B-064CAED3FFD7Q28394975-CC5CB837-BBEC-43D0-A36B-B124F4117D3EQ30151772-79CAAA1A-7A68-4F5E-A4F1-F20DF473DFD3Q30222883-3F1DB920-582A-4634-92BA-DF94385AE001Q30353883-9671B30B-58EC-407E-879D-8D8374D5DAC1Q30355817-7DA48F88-B2CC-43A4-802B-502BFF1EE13AQ30357331-C9060823-46A1-4099-BAD1-7A2DD14C3995Q30366119-2107512A-8B5A-41B6-9A18-C1F6B4831D8FQ30371419-0951D720-5A24-4E33-90D7-8ADAF6377F23Q30373137-77044E23-E4E4-4AC2-87A8-3EFF7F911649Q30381595-9CBD5FD8-717A-4735-91D3-AC9A692A1C8FQ30394818-332CDDA2-D743-4069-9775-8488905734A8Q30415221-D0DD338D-6AD2-46E0-BEA0-E1C6D209A8EFQ30417326-EB9C607F-87B4-48CB-87CA-C8FDB796CB0EQ30419138-B6CA8D6F-0997-4638-A027-4BA4AFC383C5Q30426038-257D15E0-8A25-4AC1-A6FB-06BD30F1B68DQ30428015-60D6A728-149E-40B4-8729-084657B88B96Q30432301-D7FF7AA4-F700-4E71-AAC1-A6E1BC1F9D69Q30652766-AEE99561-5379-4865-BC0B-EB767E44A624Q34853065-8051C65D-0CB9-4E92-A0E7-016073B05276Q35911143-9B36C5AF-7FDD-4C04-9376-44D8274E0275Q36511018-1FE83468-C3A2-43A7-828B-11E89BE3FEA1Q36559615-6CFBFA5F-0816-4CAA-A2EF-A17F8CA43B9DQ36570516-D017E2A6-0A4F-4219-9E2B-F010DAF2FB01Q36731466-1C52E423-B203-472E-90BE-7DC0FB5C9A64Q36760138-DF0AA0BE-E8E1-4B68-BDBC-3153DFEA5ABAQ36779818-218B25F5-2130-4F81-8240-3D796DB288AFQ36978850-796EF4DD-1756-4D48-A396-A2DA51180392Q37071349-7F864712-98A1-42B9-BBBE-FA2D5FAC004FQ37130531-5879CAB5-DCE5-4671-B351-7010204F3BC2Q37554823-3FEE5CDF-9652-42E7-BEF6-DE6A88B410A9Q40150636-8E1BA604-93B8-440C-AFBF-EED47D32235AQ41252964-1BA3248B-F589-4DBF-A035-98374CA44A18
P2860
Update: Influenza A (H3N2)v transmission and guidelines - five states, 2011.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Update: Influenza A (H3N2)v transmission and guidelines - five states, 2011.
@ast
Update: Influenza A (H3N2)v transmission and guidelines - five states, 2011.
@en
type
label
Update: Influenza A (H3N2)v transmission and guidelines - five states, 2011.
@ast
Update: Influenza A (H3N2)v transmission and guidelines - five states, 2011.
@en
prefLabel
Update: Influenza A (H3N2)v transmission and guidelines - five states, 2011.
@ast
Update: Influenza A (H3N2)v transmission and guidelines - five states, 2011.
@en
P1476
Update: Influenza A (H3N2)v transmission and guidelines - five states, 2011
@en
P304
P577
2012-01-01T00:00:00Z